Subgroup performance tables and model cards
FDA draft lifecycle guidance expects them; finalisation is on the FY2027 agenda.
What subgroup performance tables and model cards means
FDA draft lifecycle guidance expects them; finalisation is on the FY2027 agenda.
Why it matters. Regulators expect performance by subgroup and clear model documentation.
A table reports sensitivity by age, sex and scanner model.
How to measure it
Gather local scans
Use scans from your own scanners and protocols.
Adjudicate labels
Radiologists agree the reference reading.
Test across sites and groups
Check scanners, sites and patient groups separately.
Check calibration
Compare predicted and observed rates.
Performance at the vendor's test site often doesn't hold at yours.
Local sensitivity and specificity with subgroup tables, external-site results and calibration.
Report local performance with radiologist-adjudicated labels, external sites, subgroup results and calibration, against a cleared comparator.
Reviewed by the Precision research team.
How strong is the evidence
E3 · Secondary or single-source report. Reported by trade press or a single source. Directional only until checked against the primary document.
What the sources say
(RAPS).
- Clinician judgement. Needs a clinician to judge or label, because the answer depends on clinical meaning.
- RAPSraps.org
Found something out of date? Write to hello@precision.example.
Agents that measure this
Quick answers
What is subgroup performance tables and model cards in healthcare AI?
FDA draft lifecycle guidance expects them; finalisation is on the FY2027 agenda. It sits in the imaging and diagnostics group.
Why does subgroup performance tables and model cards matter?
Regulators expect performance by subgroup and clear model documentation. A table reports sensitivity by age, sex and scanner model.
How is subgroup performance tables and model cards measured?
Gather local scans, then Adjudicate labels, then Test across sites and groups, then Check calibration. Report local performance with radiologist-adjudicated labels, external sites, subgroup results and calibration, against a cleared comparator.
What should I watch out for with subgroup performance tables and model cards?
Performance at the vendor's test site often doesn't hold at yours. A good report gives: local sensitivity and specificity with subgroup tables, external-site results and calibration.
Can subgroup performance tables and model cards be automated?
Only in part. It needs clinician judgement. Software can screen, but a clinician must judge the cases that matter.